Topics

Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock

19:57 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Veracyte, Inc. (Nasdaq: VCYT) (the “Company”) today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $23.25 per share. The gross proceeds to the C...

Other Sources for this Article

Investor and Media Contact:
Angie McCabe, (650) 243-6371
angie@veracyte.com

NEXT ARTICLE

More From BioPortfolio on "Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock"

Quick Search

Relevant Topic

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...